

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratinocyte development (GO:0003334) | 4.71967207 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.55838094 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.55838094 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.27131226 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.27131226 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.15648282 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.06511870 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 3.92164497 |
| 9 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.83674477 |
| 10 | axoneme assembly (GO:0035082) | 3.80022904 |
| 11 | lysine catabolic process (GO:0006554) | 3.68177979 |
| 12 | lysine metabolic process (GO:0006553) | 3.68177979 |
| 13 | high-density lipoprotein particle remodeling (GO:0034375) | 3.66945510 |
| 14 | bile acid biosynthetic process (GO:0006699) | 3.66369286 |
| 15 | kynurenine metabolic process (GO:0070189) | 3.52093786 |
| 16 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.49295309 |
| 17 | regulation of cholesterol homeostasis (GO:2000188) | 3.44540078 |
| 18 | reverse cholesterol transport (GO:0043691) | 3.41773424 |
| 19 | respiratory chain complex IV assembly (GO:0008535) | 3.41657494 |
| 20 | tryptophan catabolic process (GO:0006569) | 3.38568308 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 3.38568308 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 3.38568308 |
| 23 | urea cycle (GO:0000050) | 3.37430017 |
| 24 | urea metabolic process (GO:0019627) | 3.37430017 |
| 25 | fucose catabolic process (GO:0019317) | 3.36255214 |
| 26 | L-fucose metabolic process (GO:0042354) | 3.36255214 |
| 27 | L-fucose catabolic process (GO:0042355) | 3.36255214 |
| 28 | tryptophan metabolic process (GO:0006568) | 3.35290676 |
| 29 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.34800449 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 3.31567565 |
| 31 | response to pheromone (GO:0019236) | 3.31285122 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.31174837 |
| 33 | cysteine metabolic process (GO:0006534) | 3.28994084 |
| 34 | protein polyglutamylation (GO:0018095) | 3.28359500 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 3.28256591 |
| 36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.27698895 |
| 37 | protein carboxylation (GO:0018214) | 3.27698895 |
| 38 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.27511614 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 3.26142046 |
| 40 | regulation of hexokinase activity (GO:1903299) | 3.25818699 |
| 41 | regulation of glucokinase activity (GO:0033131) | 3.25818699 |
| 42 | sulfur amino acid catabolic process (GO:0000098) | 3.23842552 |
| 43 | glutamate metabolic process (GO:0006536) | 3.23688644 |
| 44 | bile acid metabolic process (GO:0008206) | 3.23086219 |
| 45 | auditory receptor cell differentiation (GO:0042491) | 3.22826536 |
| 46 | regulation of bile acid biosynthetic process (GO:0070857) | 3.22525077 |
| 47 | complement activation, alternative pathway (GO:0006957) | 3.22416296 |
| 48 | acylglycerol homeostasis (GO:0055090) | 3.21122382 |
| 49 | triglyceride homeostasis (GO:0070328) | 3.21122382 |
| 50 | indolalkylamine metabolic process (GO:0006586) | 3.20679760 |
| 51 | platelet dense granule organization (GO:0060155) | 3.19564347 |
| 52 | positive regulation of fatty acid oxidation (GO:0046321) | 3.19561640 |
| 53 | 2-oxoglutarate metabolic process (GO:0006103) | 3.19069774 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 3.19022919 |
| 55 | macromolecular complex remodeling (GO:0034367) | 3.19022919 |
| 56 | plasma lipoprotein particle remodeling (GO:0034369) | 3.19022919 |
| 57 | positive regulation of meiosis (GO:0045836) | 3.19002090 |
| 58 | glyoxylate metabolic process (GO:0046487) | 3.17130464 |
| 59 | ketone body metabolic process (GO:1902224) | 3.16248900 |
| 60 | drug catabolic process (GO:0042737) | 3.14278486 |
| 61 | positive regulation of meiotic cell cycle (GO:0051446) | 3.14122665 |
| 62 | regulation of protein activation cascade (GO:2000257) | 3.12320137 |
| 63 | protein localization to cilium (GO:0061512) | 3.10953469 |
| 64 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.10070915 |
| 65 | regulation of fibrinolysis (GO:0051917) | 3.08490895 |
| 66 | phospholipid homeostasis (GO:0055091) | 3.08444271 |
| 67 | regulation of acrosome reaction (GO:0060046) | 3.08306998 |
| 68 | epithelial cilium movement (GO:0003351) | 3.07738175 |
| 69 | homocysteine metabolic process (GO:0050667) | 3.07212454 |
| 70 | S-adenosylmethionine metabolic process (GO:0046500) | 3.05661150 |
| 71 | positive regulation of lipid catabolic process (GO:0050996) | 3.04208487 |
| 72 | nitrogen cycle metabolic process (GO:0071941) | 3.03716932 |
| 73 | regulation of meiosis I (GO:0060631) | 3.02592524 |
| 74 | flavonoid metabolic process (GO:0009812) | 3.02129642 |
| 75 | cellular response to ATP (GO:0071318) | 2.99181864 |
| 76 | piRNA metabolic process (GO:0034587) | 2.99108228 |
| 77 | cytochrome complex assembly (GO:0017004) | 2.98801410 |
| 78 | cellular glucuronidation (GO:0052695) | 2.98707183 |
| 79 | adaptation of signaling pathway (GO:0023058) | 2.96838077 |
| 80 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.96498279 |
| 81 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.96498279 |
| 82 | regulation of complement activation (GO:0030449) | 2.95422373 |
| 83 | negative regulation of lipase activity (GO:0060192) | 2.95283462 |
| 84 | phospholipid efflux (GO:0033700) | 2.95063008 |
| 85 | tyrosine metabolic process (GO:0006570) | 2.93319346 |
| 86 | glycerophospholipid catabolic process (GO:0046475) | 2.92476996 |
| 87 | amine catabolic process (GO:0009310) | 2.91873748 |
| 88 | cellular biogenic amine catabolic process (GO:0042402) | 2.91873748 |
| 89 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.91602209 |
| 90 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.91602209 |
| 91 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.90555024 |
| 92 | protein K11-linked deubiquitination (GO:0035871) | 2.90071619 |
| 93 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.90053154 |
| 94 | cellular modified amino acid catabolic process (GO:0042219) | 2.89623445 |
| 95 | fatty acid transmembrane transport (GO:1902001) | 2.89368088 |
| 96 | short-chain fatty acid metabolic process (GO:0046459) | 2.89032831 |
| 97 | cellular ketone body metabolic process (GO:0046950) | 2.88384647 |
| 98 | negative regulation of sterol transport (GO:0032372) | 2.88331032 |
| 99 | negative regulation of cholesterol transport (GO:0032375) | 2.88331032 |
| 100 | alpha-amino acid catabolic process (GO:1901606) | 2.87685313 |
| 101 | detection of light stimulus involved in visual perception (GO:0050908) | 2.86321742 |
| 102 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.86321742 |
| 103 | positive regulation of glomerulus development (GO:0090193) | 2.85604199 |
| 104 | cornea development in camera-type eye (GO:0061303) | 2.84579217 |
| 105 | polyol catabolic process (GO:0046174) | 2.83244540 |
| 106 | regulation of cholesterol esterification (GO:0010872) | 2.82724586 |
| 107 | plasma lipoprotein particle clearance (GO:0034381) | 2.82514754 |
| 108 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.80389978 |
| 109 | serine family amino acid catabolic process (GO:0009071) | 2.79329980 |
| 110 | valine metabolic process (GO:0006573) | 2.79210628 |
| 111 | positive regulation of protein autophosphorylation (GO:0031954) | 2.79041954 |
| 112 | cholesterol efflux (GO:0033344) | 2.78792475 |
| 113 | fatty acid beta-oxidation (GO:0006635) | 2.78685889 |
| 114 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.78238145 |
| 115 | regulation of triglyceride metabolic process (GO:0090207) | 2.77870726 |
| 116 | fatty acid oxidation (GO:0019395) | 2.77705122 |
| 117 | carnitine metabolic process (GO:0009437) | 2.77459654 |
| 118 | lipid oxidation (GO:0034440) | 2.75614907 |
| 119 | exogenous drug catabolic process (GO:0042738) | 2.74535592 |
| 120 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.74057385 |
| 121 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.73354730 |
| 122 | cilium movement (GO:0003341) | 2.73057680 |
| 123 | aromatic amino acid family metabolic process (GO:0009072) | 2.72221994 |
| 124 | cellular amino acid catabolic process (GO:0009063) | 2.71423957 |
| 125 | prostate gland growth (GO:0060736) | 2.70610478 |
| 126 | carnitine shuttle (GO:0006853) | 2.69782636 |
| 127 | aspartate family amino acid catabolic process (GO:0009068) | 2.69114227 |
| 128 | monocarboxylic acid catabolic process (GO:0072329) | 2.69094091 |
| 129 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.69093945 |
| 130 | intestinal cholesterol absorption (GO:0030299) | 2.67034161 |
| 131 | multicellular organism reproduction (GO:0032504) | 2.66859938 |
| 132 | protein K6-linked ubiquitination (GO:0085020) | 2.66135691 |
| 133 | retinal cone cell development (GO:0046549) | 2.65964303 |
| 134 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.65478279 |
| 135 | negative regulation of complement activation (GO:0045916) | 2.65372851 |
| 136 | benzene-containing compound metabolic process (GO:0042537) | 2.65302630 |
| 137 | behavioral response to nicotine (GO:0035095) | 2.65268502 |
| 138 | fatty acid catabolic process (GO:0009062) | 2.64479820 |
| 139 | bile acid and bile salt transport (GO:0015721) | 2.63145662 |
| 140 | regulation of glomerulus development (GO:0090192) | 2.60403258 |
| 141 | DNA deamination (GO:0045006) | 2.59877241 |
| 142 | plasma lipoprotein particle assembly (GO:0034377) | 2.59348696 |
| 143 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.59282997 |
| 144 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.59282997 |
| 145 | estrogen metabolic process (GO:0008210) | 2.58352536 |
| 146 | negative regulation of JUN kinase activity (GO:0043508) | 2.58175877 |
| 147 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.57885980 |
| 148 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.57867182 |
| 149 | photoreceptor cell maintenance (GO:0045494) | 2.57277358 |
| 150 | sterol catabolic process (GO:0016127) | 2.56865771 |
| 151 | cholesterol catabolic process (GO:0006707) | 2.56865771 |
| 152 | negative regulation of dendrite development (GO:2000171) | 2.56513222 |
| 153 | cilium morphogenesis (GO:0060271) | 2.55144322 |
| 154 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.55075844 |
| 155 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.54327687 |
| 156 | cilium organization (GO:0044782) | 2.54225468 |
| 157 | kidney morphogenesis (GO:0060993) | 2.52882236 |
| 158 | regulation of fatty acid oxidation (GO:0046320) | 2.52877196 |
| 159 | inositol phosphate catabolic process (GO:0071545) | 2.52474177 |
| 160 | drug metabolic process (GO:0017144) | 2.52342260 |
| 161 | plasma lipoprotein particle organization (GO:0071827) | 2.52112700 |
| 162 | drug transmembrane transport (GO:0006855) | 2.51153874 |
| 163 | regulation of action potential (GO:0098900) | 2.50729365 |
| 164 | organic acid catabolic process (GO:0016054) | 2.50281723 |
| 165 | carboxylic acid catabolic process (GO:0046395) | 2.50281723 |
| 166 | glucuronate metabolic process (GO:0019585) | 2.49691085 |
| 167 | uronic acid metabolic process (GO:0006063) | 2.49691085 |
| 168 | endocrine pancreas development (GO:0031018) | 2.49141788 |
| 169 | reflex (GO:0060004) | 2.48629628 |
| 170 | alanine transport (GO:0032328) | 2.48067003 |
| 171 | indole-containing compound metabolic process (GO:0042430) | 2.46778204 |
| 172 | regulation of cilium movement (GO:0003352) | 2.45568171 |
| 173 | GPI anchor metabolic process (GO:0006505) | 2.45274552 |
| 174 | intraciliary transport (GO:0042073) | 2.43414548 |
| 175 | cilium assembly (GO:0042384) | 2.42851235 |
| 176 | sphingomyelin metabolic process (GO:0006684) | 2.42627768 |
| 177 | proline transport (GO:0015824) | 2.42056680 |
| 178 | smooth muscle tissue development (GO:0048745) | 2.40989558 |
| 179 | phenylpropanoid metabolic process (GO:0009698) | 2.38068341 |
| 180 | embryonic epithelial tube formation (GO:0001838) | 2.36802088 |
| 181 | nephron tubule formation (GO:0072079) | 2.36193992 |
| 182 | DNA methylation involved in gamete generation (GO:0043046) | 2.35882995 |
| 183 | xenobiotic catabolic process (GO:0042178) | 2.35315332 |
| 184 | transepithelial transport (GO:0070633) | 2.34365713 |
| 185 | regulation of protein glycosylation (GO:0060049) | 2.33987648 |
| 186 | dentate gyrus development (GO:0021542) | 2.33772091 |
| 187 | gamma-aminobutyric acid transport (GO:0015812) | 2.33142503 |
| 188 | insulin secretion (GO:0030073) | 2.32800894 |
| 189 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.31205947 |
| 190 | dopamine transport (GO:0015872) | 2.30864148 |
| 191 | negative regulation of protein activation cascade (GO:2000258) | 2.29201313 |
| 192 | organic cation transport (GO:0015695) | 2.28263098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.48498788 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.74250469 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.15111807 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.56760535 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.39808780 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.02117758 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.98972632 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.88084993 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.77515525 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.63779234 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.59671581 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.54533888 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.51204770 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.42157111 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.39531538 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.27739999 |
| 17 | FUS_26573619_Chip-Seq_HEK293_Human | 2.09378370 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.05029007 |
| 19 | P300_19829295_ChIP-Seq_ESCs_Human | 2.02250462 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.98805393 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.94367694 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90922757 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.85302115 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78627910 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 1.76434337 |
| 26 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.75436596 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.72138647 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.67971104 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64387750 |
| 30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.62213900 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60560506 |
| 32 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59268653 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58202822 |
| 34 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.57704754 |
| 35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.57273998 |
| 36 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.57077920 |
| 37 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.55524023 |
| 38 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.55524023 |
| 39 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.54597107 |
| 40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.53334538 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.53124306 |
| 42 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.51511668 |
| 43 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50897530 |
| 44 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50783301 |
| 45 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.50231284 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50098785 |
| 47 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.50090985 |
| 48 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.48231338 |
| 49 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47079073 |
| 50 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.46602626 |
| 51 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.45860309 |
| 52 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.45716894 |
| 53 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.45227691 |
| 54 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.44814470 |
| 55 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.43143165 |
| 56 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.42615901 |
| 57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41890458 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41738559 |
| 59 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.40431986 |
| 60 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.40431986 |
| 61 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39130205 |
| 62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39094005 |
| 63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.38494160 |
| 64 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38307767 |
| 65 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38307767 |
| 66 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.38217384 |
| 67 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.38123663 |
| 68 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.37831161 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35008123 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33822052 |
| 71 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.33436759 |
| 72 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.32159397 |
| 73 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.31660444 |
| 74 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.31518483 |
| 75 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.30366950 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30274240 |
| 77 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29869324 |
| 78 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.29639134 |
| 79 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.29076562 |
| 80 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.29045758 |
| 81 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28975105 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28855683 |
| 83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27604559 |
| 84 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.27539971 |
| 85 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.22517833 |
| 86 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21885381 |
| 87 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.21799272 |
| 88 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21189665 |
| 89 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.21076009 |
| 90 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.20518277 |
| 91 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20460100 |
| 92 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19869417 |
| 93 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19256128 |
| 94 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19256128 |
| 95 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18879089 |
| 96 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.18854755 |
| 97 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16872640 |
| 98 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.16482011 |
| 99 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15774858 |
| 100 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15205470 |
| 101 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.14491931 |
| 102 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14294082 |
| 103 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14279760 |
| 104 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14107926 |
| 105 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13276464 |
| 106 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.12245979 |
| 107 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11503956 |
| 108 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.10730818 |
| 109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10642338 |
| 110 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.09373068 |
| 111 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.09329196 |
| 112 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.08316543 |
| 113 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.07190082 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06947933 |
| 115 | NCOR_22424771_ChIP-Seq_293T_Human | 1.05295824 |
| 116 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.05146804 |
| 117 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04973757 |
| 118 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.04898201 |
| 119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04855833 |
| 120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04662075 |
| 121 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04541204 |
| 122 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04180362 |
| 123 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.03428819 |
| 124 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03097978 |
| 125 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.02846799 |
| 126 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02785537 |
| 127 | TBL1_22424771_ChIP-Seq_293T_Human | 1.01820191 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00727074 |
| 129 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00627321 |
| 130 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00547793 |
| 131 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00242673 |
| 132 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00157827 |
| 133 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.99759125 |
| 134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99423134 |
| 135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97340156 |
| 136 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.97058237 |
| 137 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96961033 |
| 138 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.96472840 |
| 139 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94901991 |
| 140 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93996521 |
| 141 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93996521 |
| 142 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.93713992 |
| 143 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92615772 |
| 144 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92377166 |
| 145 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92097258 |
| 146 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91417077 |
| 147 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90961688 |
| 148 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90961688 |
| 149 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90446157 |
| 150 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89434865 |
| 151 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88801090 |
| 152 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88129623 |
| 153 | * AR_19668381_ChIP-Seq_PC3_Human | 0.87554907 |
| 154 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.87159711 |
| 155 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87099253 |
| 156 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86827842 |
| 157 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86625577 |
| 158 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86524255 |
| 159 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85677023 |
| 160 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85656085 |
| 161 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.85636272 |
| 162 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85075422 |
| 163 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84925922 |
| 164 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.84754011 |
| 165 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84672993 |
| 166 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83791791 |
| 167 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.83670817 |
| 168 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83071327 |
| 169 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82122899 |
| 170 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81493273 |
| 171 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81461563 |
| 172 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81298901 |
| 173 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81244096 |
| 174 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80401997 |
| 175 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79849312 |
| 176 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.78513382 |
| 177 | STAT3_23295773_ChIP-Seq_U87_Human | 0.76999040 |
| 178 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.76702725 |
| 179 | TP53_16413492_ChIP-PET_HCT116_Human | 0.74978852 |
| 180 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70914385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.86896063 |
| 2 | MP0005360_urolithiasis | 5.18410982 |
| 3 | MP0005365_abnormal_bile_salt | 4.65310309 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.48729720 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.14931492 |
| 6 | MP0003252_abnormal_bile_duct | 3.04910784 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.02890760 |
| 8 | MP0005379_endocrine/exocrine_gland_phen | 2.70331337 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.60060662 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.57798298 |
| 11 | MP0005645_abnormal_hypothalamus_physiol | 2.48470298 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.21993837 |
| 13 | MP0006072_abnormal_retinal_apoptosis | 2.21961158 |
| 14 | MP0002822_catalepsy | 2.21471539 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.20618901 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.18399990 |
| 17 | MP0005083_abnormal_biliary_tract | 2.15599504 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 2.12052542 |
| 19 | MP0005332_abnormal_amino_acid | 2.11181308 |
| 20 | MP0002163_abnormal_gland_morphology | 2.02814946 |
| 21 | MP0003787_abnormal_imprinting | 2.01772897 |
| 22 | MP0009046_muscle_twitch | 2.01038318 |
| 23 | MP0004130_abnormal_muscle_cell | 1.99525594 |
| 24 | MP0005670_abnormal_white_adipose | 1.99410164 |
| 25 | MP0009840_abnormal_foam_cell | 1.98332458 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.97929376 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.93615923 |
| 28 | MP0000631_abnormal_neuroendocrine_gland | 1.92472001 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.91950066 |
| 30 | MP0003195_calcinosis | 1.87697732 |
| 31 | MP0002638_abnormal_pupillary_reflex | 1.81812068 |
| 32 | MP0005253_abnormal_eye_physiology | 1.65751956 |
| 33 | MP0000427_abnormal_hair_cycle | 1.64456811 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.59767598 |
| 35 | MP0001485_abnormal_pinna_reflex | 1.56767960 |
| 36 | MP0000609_abnormal_liver_physiology | 1.56364885 |
| 37 | MP0003868_abnormal_feces_composition | 1.46402499 |
| 38 | MP0003329_amyloid_beta_deposits | 1.44570990 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.41119730 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.40377257 |
| 41 | MP0004043_abnormal_pH_regulation | 1.40269019 |
| 42 | * MP0005535_abnormal_body_temperature | 1.39904523 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.38840197 |
| 44 | MP0003635_abnormal_synaptic_transmissio | 1.38610071 |
| 45 | MP0010678_abnormal_skin_adnexa | 1.37368135 |
| 46 | * MP0008961_abnormal_basal_metabolism | 1.36507718 |
| 47 | MP0005389_reproductive_system_phenotype | 1.35636395 |
| 48 | MP0002102_abnormal_ear_morphology | 1.34616689 |
| 49 | MP0003718_maternal_effect | 1.34096736 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 1.32768424 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.32565455 |
| 52 | MP0000383_abnormal_hair_follicle | 1.30963550 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29699158 |
| 54 | MP0002160_abnormal_reproductive_system | 1.29494489 |
| 55 | MP0000751_myopathy | 1.28960223 |
| 56 | MP0001968_abnormal_touch/_nociception | 1.28908782 |
| 57 | MP0005666_abnormal_adipose_tissue | 1.28846418 |
| 58 | MP0000372_irregular_coat_pigmentation | 1.28377398 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.24958764 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.18240686 |
| 61 | * MP0009745_abnormal_behavioral_response | 1.17805029 |
| 62 | MP0002971_abnormal_brown_adipose | 1.17674501 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.17590342 |
| 64 | MP0004133_heterotaxia | 1.16324810 |
| 65 | MP0002938_white_spotting | 1.16284675 |
| 66 | MP0000013_abnormal_adipose_tissue | 1.15752673 |
| 67 | MP0003646_muscle_fatigue | 1.14612048 |
| 68 | MP0002254_reproductive_system_inflammat | 1.14584929 |
| 69 | MP0002876_abnormal_thyroid_physiology | 1.13192301 |
| 70 | MP0004036_abnormal_muscle_relaxation | 1.12788023 |
| 71 | MP0004215_abnormal_myocardial_fiber | 1.12685289 |
| 72 | MP0009643_abnormal_urine_homeostasis | 1.10020630 |
| 73 | MP0005174_abnormal_tail_pigmentation | 1.08536899 |
| 74 | MP0003075_altered_response_to | 1.08062878 |
| 75 | MP0000604_amyloidosis | 1.08048262 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.06663915 |
| 77 | MP0004924_abnormal_behavior | 1.06663915 |
| 78 | * MP0002063_abnormal_learning/memory/cond | 1.05480275 |
| 79 | MP0010368_abnormal_lymphatic_system | 1.04605806 |
| 80 | MP0002282_abnormal_trachea_morphology | 1.04335013 |
| 81 | MP0000569_abnormal_digit_pigmentation | 1.03307159 |
| 82 | MP0001765_abnormal_ion_homeostasis | 1.01390359 |
| 83 | MP0003690_abnormal_glial_cell | 1.00871131 |
| 84 | MP0001986_abnormal_taste_sensitivity | 1.00324344 |
| 85 | MP0001919_abnormal_reproductive_system | 0.98513074 |
| 86 | MP0005334_abnormal_fat_pad | 0.98276004 |
| 87 | MP0005448_abnormal_energy_balance | 0.97749347 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.96281117 |
| 89 | * MP0001501_abnormal_sleep_pattern | 0.96232209 |
| 90 | MP0000639_abnormal_adrenal_gland | 0.95346532 |
| 91 | MP0003705_abnormal_hypodermis_morpholog | 0.95298573 |
| 92 | MP0005375_adipose_tissue_phenotype | 0.95036777 |
| 93 | * MP0001502_abnormal_circadian_rhythm | 0.94474077 |
| 94 | MP0004142_abnormal_muscle_tone | 0.93825134 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 0.93792391 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.93286329 |
| 97 | MP0001984_abnormal_olfaction | 0.92436055 |
| 98 | MP0003633_abnormal_nervous_system | 0.92231841 |
| 99 | * MP0002557_abnormal_social/conspecific_i | 0.91184793 |
| 100 | MP0005410_abnormal_fertilization | 0.90723163 |
| 101 | MP0003953_abnormal_hormone_level | 0.90500958 |
| 102 | MP0005395_other_phenotype | 0.90275421 |
| 103 | MP0003879_abnormal_hair_cell | 0.90182418 |
| 104 | MP0004270_analgesia | 0.88898388 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.88561951 |
| 106 | MP0008058_abnormal_DNA_repair | 0.87433497 |
| 107 | MP0002090_abnormal_vision | 0.86948738 |
| 108 | MP0002064_seizures | 0.86939211 |
| 109 | MP0002009_preneoplasia | 0.86513156 |
| 110 | MP0002229_neurodegeneration | 0.85674128 |
| 111 | MP0005636_abnormal_mineral_homeostasis | 0.85362075 |
| 112 | MP0001764_abnormal_homeostasis | 0.84214220 |
| 113 | MP0001944_abnormal_pancreas_morphology | 0.83098977 |
| 114 | MP0002572_abnormal_emotion/affect_behav | 0.82766177 |
| 115 | MP0002168_other_aberrant_phenotype | 0.81257032 |
| 116 | MP0003011_delayed_dark_adaptation | 0.80508201 |
| 117 | MP0005330_cardiomyopathy | 0.80182728 |
| 118 | MP0001486_abnormal_startle_reflex | 0.79620196 |
| 119 | MP0000516_abnormal_urinary_system | 0.79304835 |
| 120 | MP0005367_renal/urinary_system_phenotyp | 0.79304835 |
| 121 | MP0003880_abnormal_central_pattern | 0.78796399 |
| 122 | MP0008872_abnormal_physiological_respon | 0.78431260 |
| 123 | MP0001970_abnormal_pain_threshold | 0.78405639 |
| 124 | MP0000015_abnormal_ear_pigmentation | 0.78126040 |
| 125 | MP0004085_abnormal_heartbeat | 0.78108480 |
| 126 | MP0008874_decreased_physiological_sensi | 0.77207348 |
| 127 | MP0003943_abnormal_hepatobiliary_system | 0.77131547 |
| 128 | MP0006276_abnormal_autonomic_nervous | 0.76810240 |
| 129 | MP0001756_abnormal_urination | 0.76708788 |
| 130 | MP0004084_abnormal_cardiac_muscle | 0.76708499 |
| 131 | MP0005220_abnormal_exocrine_pancreas | 0.76664822 |
| 132 | MP0002928_abnormal_bile_duct | 0.76546807 |
| 133 | MP0000749_muscle_degeneration | 0.75591883 |
| 134 | MP0004134_abnormal_chest_morphology | 0.75540915 |
| 135 | MP0003300_gastrointestinal_ulcer | 0.74782521 |
| 136 | MP0005310_abnormal_salivary_gland | 0.74365008 |
| 137 | MP0005084_abnormal_gallbladder_morpholo | 0.74310943 |
| 138 | MP0005620_abnormal_muscle_contractility | 0.74145827 |
| 139 | MP0004087_abnormal_muscle_fiber | 0.73536885 |
| 140 | MP0009642_abnormal_blood_homeostasis | 0.73255311 |
| 141 | MP0004185_abnormal_adipocyte_glucose | 0.73038908 |
| 142 | MP0002735_abnormal_chemical_nociception | 0.72189702 |
| 143 | MP0001440_abnormal_grooming_behavior | 0.71264290 |
| 144 | MP0005167_abnormal_blood-brain_barrier | 0.70268433 |
| 145 | MP0006138_congestive_heart_failure | 0.70230803 |
| 146 | MP0002269_muscular_atrophy | 0.69770059 |
| 147 | MP0002272_abnormal_nervous_system | 0.68748975 |
| 148 | MP0004858_abnormal_nervous_system | 0.68096703 |
| 149 | MP0003656_abnormal_erythrocyte_physiolo | 0.67638998 |
| 150 | MP0004885_abnormal_endolymph | 0.66289901 |
| 151 | MP0000003_abnormal_adipose_tissue | 0.65680518 |
| 152 | MP0005647_abnormal_sex_gland | 0.64423277 |
| 153 | MP0002693_abnormal_pancreas_physiology | 0.62733295 |
| 154 | MP0005166_decreased_susceptibility_to | 0.62640854 |
| 155 | MP0006036_abnormal_mitochondrial_physio | 0.60569550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.94274637 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.67073110 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.66390878 |
| 4 | Xanthomatosis (HP:0000991) | 4.51352581 |
| 5 | Hypoglycemic coma (HP:0001325) | 4.23902897 |
| 6 | Ketosis (HP:0001946) | 4.20346265 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.14942659 |
| 8 | Ketoacidosis (HP:0001993) | 3.94421657 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 3.92217760 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 3.88201151 |
| 11 | Pancreatic cysts (HP:0001737) | 3.87145932 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.80344063 |
| 13 | True hermaphroditism (HP:0010459) | 3.74617597 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 3.60330420 |
| 15 | Complement deficiency (HP:0004431) | 3.44734449 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 3.43052914 |
| 17 | Hypothermia (HP:0002045) | 3.31092258 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.28608280 |
| 19 | Hyperammonemia (HP:0001987) | 3.27183938 |
| 20 | Epidermoid cyst (HP:0200040) | 3.26476271 |
| 21 | Nephronophthisis (HP:0000090) | 3.24334013 |
| 22 | Hyperglycinuria (HP:0003108) | 3.19932364 |
| 23 | Hypoglycemic seizures (HP:0002173) | 3.17661775 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.07725353 |
| 25 | Large for gestational age (HP:0001520) | 3.07425984 |
| 26 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.06189801 |
| 27 | Pendular nystagmus (HP:0012043) | 3.04502567 |
| 28 | Gout (HP:0001997) | 3.04325392 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.03171872 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 2.99721286 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.99073483 |
| 32 | Abnormality of the renal cortex (HP:0011035) | 2.98799897 |
| 33 | Intestinal atresia (HP:0011100) | 2.98301362 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 2.96007500 |
| 35 | Molar tooth sign on MRI (HP:0002419) | 2.96007500 |
| 36 | Cystic liver disease (HP:0006706) | 2.91923562 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 2.90383002 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.90383002 |
| 39 | Abnormality of the renal medulla (HP:0100957) | 2.89147924 |
| 40 | Hyperglycinemia (HP:0002154) | 2.86287199 |
| 41 | Methylmalonic acidemia (HP:0002912) | 2.80377068 |
| 42 | Skin nodule (HP:0200036) | 2.79588574 |
| 43 | Progressive cerebellar ataxia (HP:0002073) | 2.77984333 |
| 44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.77199166 |
| 45 | Hemiparesis (HP:0001269) | 2.77138677 |
| 46 | Hyperglycemia (HP:0003074) | 2.76856289 |
| 47 | Abnormality of vitamin B metabolism (HP:0004340) | 2.74975585 |
| 48 | Congenital stationary night blindness (HP:0007642) | 2.74691278 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.71394112 |
| 50 | Abnormality of the intrinsic pathway (HP:0010989) | 2.66138952 |
| 51 | Joint hemorrhage (HP:0005261) | 2.62337755 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.62261858 |
| 53 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.58380516 |
| 54 | Attenuation of retinal blood vessels (HP:0007843) | 2.56926560 |
| 55 | Fat malabsorption (HP:0002630) | 2.56410833 |
| 56 | Hypercholesterolemia (HP:0003124) | 2.56380594 |
| 57 | Late onset (HP:0003584) | 2.55045547 |
| 58 | Tubular atrophy (HP:0000092) | 2.52554580 |
| 59 | Furrowed tongue (HP:0000221) | 2.49635015 |
| 60 | Abnormality of methionine metabolism (HP:0010901) | 2.45136499 |
| 61 | Medial flaring of the eyebrow (HP:0010747) | 2.44196609 |
| 62 | Delayed CNS myelination (HP:0002188) | 2.44042058 |
| 63 | Conjugated hyperbilirubinemia (HP:0002908) | 2.42449143 |
| 64 | Metabolic acidosis (HP:0001942) | 2.39635423 |
| 65 | Abolished electroretinogram (ERG) (HP:0000550) | 2.39405110 |
| 66 | Hamartoma of the eye (HP:0010568) | 2.39375605 |
| 67 | Exercise-induced myalgia (HP:0003738) | 2.36018528 |
| 68 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.35806122 |
| 69 | Myoglobinuria (HP:0002913) | 2.35079008 |
| 70 | Hyperkalemia (HP:0002153) | 2.33140683 |
| 71 | Aqueductal stenosis (HP:0002410) | 2.31649739 |
| 72 | Symptomatic seizures (HP:0011145) | 2.31229529 |
| 73 | Abnormality of complement system (HP:0005339) | 2.30893769 |
| 74 | Genetic anticipation (HP:0003743) | 2.27704969 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.27540142 |
| 76 | Congenital sensorineural hearing impairment (HP:0008527) | 2.23933518 |
| 77 | Increased circulating renin level (HP:0000848) | 2.23195669 |
| 78 | Hyperbilirubinemia (HP:0002904) | 2.22977884 |
| 79 | Polydipsia (HP:0001959) | 2.22957248 |
| 80 | Abnormal drinking behavior (HP:0030082) | 2.22957248 |
| 81 | Decreased circulating renin level (HP:0003351) | 2.22087170 |
| 82 | Abnormality of the nasal septum (HP:0000419) | 2.21473746 |
| 83 | Hyperventilation (HP:0002883) | 2.20679224 |
| 84 | Methylmalonic aciduria (HP:0012120) | 2.20631151 |
| 85 | Focal motor seizures (HP:0011153) | 2.20014311 |
| 86 | Short hallux (HP:0010109) | 2.18553120 |
| 87 | Myocardial infarction (HP:0001658) | 2.17616790 |
| 88 | Type II lissencephaly (HP:0007260) | 2.16673696 |
| 89 | Status epilepticus (HP:0002133) | 2.13841910 |
| 90 | Renal cortical cysts (HP:0000803) | 2.13580517 |
| 91 | Abnormality of nucleobase metabolism (HP:0010932) | 2.12205867 |
| 92 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.11541961 |
| 93 | Abnormality of macular pigmentation (HP:0008002) | 2.11078315 |
| 94 | Abnormality of vitamin metabolism (HP:0100508) | 2.10860288 |
| 95 | Dysmetric saccades (HP:0000641) | 2.10650402 |
| 96 | Abnormal gallbladder morphology (HP:0012437) | 2.08410290 |
| 97 | Agitation (HP:0000713) | 2.07857709 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 2.07241915 |
| 99 | Labial hypoplasia (HP:0000066) | 2.06417293 |
| 100 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.06287535 |
| 101 | Neonatal onset (HP:0003623) | 2.06216126 |
| 102 | Decreased central vision (HP:0007663) | 2.06143030 |
| 103 | Hypoplastic labia majora (HP:0000059) | 2.04241300 |
| 104 | Dicarboxylic aciduria (HP:0003215) | 2.04051831 |
| 105 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.04051831 |
| 106 | Hyperactive renin-angiotensin system (HP:0000841) | 2.02599912 |
| 107 | Hyperuricemia (HP:0002149) | 2.02352447 |
| 108 | Increased purine levels (HP:0004368) | 2.02352447 |
| 109 | Severe visual impairment (HP:0001141) | 2.00702622 |
| 110 | Cholelithiasis (HP:0001081) | 2.00307173 |
| 111 | Male pseudohermaphroditism (HP:0000037) | 1.98693759 |
| 112 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.97473894 |
| 113 | Absent/shortened dynein arms (HP:0200106) | 1.97473894 |
| 114 | Keratoconus (HP:0000563) | 1.97036621 |
| 115 | Increased corneal curvature (HP:0100692) | 1.97036621 |
| 116 | Oligodactyly (hands) (HP:0001180) | 1.94104460 |
| 117 | Broad-based gait (HP:0002136) | 1.93997142 |
| 118 | Sudden death (HP:0001699) | 1.93322844 |
| 119 | Fair hair (HP:0002286) | 1.93304888 |
| 120 | Atrioventricular block (HP:0001678) | 1.92345791 |
| 121 | Broad metatarsal (HP:0001783) | 1.92108420 |
| 122 | Thyroiditis (HP:0100646) | 1.91620608 |
| 123 | Mitral stenosis (HP:0001718) | 1.91504603 |
| 124 | Congenital, generalized hypertrichosis (HP:0004540) | 1.89866393 |
| 125 | Generalized aminoaciduria (HP:0002909) | 1.89254827 |
| 126 | Abnormality of serum amino acid levels (HP:0003112) | 1.89022682 |
| 127 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.88990857 |
| 128 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.88693111 |
| 129 | Chronic hepatic failure (HP:0100626) | 1.88537761 |
| 130 | Congenital hepatic fibrosis (HP:0002612) | 1.88430617 |
| 131 | Long toe (HP:0010511) | 1.88196899 |
| 132 | Polyuria (HP:0000103) | 1.87958768 |
| 133 | Syncope (HP:0001279) | 1.87605171 |
| 134 | Abnormality of proline metabolism (HP:0010907) | 1.87374955 |
| 135 | Hydroxyprolinuria (HP:0003080) | 1.87374955 |
| 136 | Adrenal hypoplasia (HP:0000835) | 1.86916172 |
| 137 | Widely spaced teeth (HP:0000687) | 1.86593558 |
| 138 | Progressive macrocephaly (HP:0004481) | 1.85778585 |
| 139 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.85361994 |
| 140 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.85361994 |
| 141 | Abnormal social behavior (HP:0012433) | 1.84007107 |
| 142 | Impaired social interactions (HP:0000735) | 1.84007107 |
| 143 | Turricephaly (HP:0000262) | 1.83669796 |
| 144 | Absent speech (HP:0001344) | 1.83199857 |
| 145 | Abnormality of the labia majora (HP:0012881) | 1.83111163 |
| 146 | Visual hallucinations (HP:0002367) | 1.82853807 |
| 147 | Confusion (HP:0001289) | 1.82397564 |
| 148 | Hypoplasia of the uterus (HP:0000013) | 1.82067008 |
| 149 | Abnormal ciliary motility (HP:0012262) | 1.81772980 |
| 150 | Abnormality of renin-angiotensin system (HP:0000847) | 1.81225496 |
| 151 | Abnormality of the parathyroid morphology (HP:0011766) | 1.80999570 |
| 152 | Enlarged kidneys (HP:0000105) | 1.80862663 |
| 153 | EEG with generalized epileptiform discharges (HP:0011198) | 1.80445920 |
| 154 | Right ventricular cardiomyopathy (HP:0011663) | 1.79806782 |
| 155 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.79570772 |
| 156 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.79570772 |
| 157 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.79452604 |
| 158 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.79139128 |
| 159 | Febrile seizures (HP:0002373) | 1.78942641 |
| 160 | Esophageal varix (HP:0002040) | 1.78407158 |
| 161 | Epileptiform EEG discharges (HP:0011182) | 1.78264967 |
| 162 | Prolonged QT interval (HP:0001657) | 1.78187262 |
| 163 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.77673352 |
| 164 | Hypsarrhythmia (HP:0002521) | 1.77581164 |
| 165 | Rhinitis (HP:0012384) | 1.77056230 |
| 166 | Bile duct proliferation (HP:0001408) | 1.77019125 |
| 167 | Abnormal biliary tract physiology (HP:0012439) | 1.77019125 |
| 168 | Abnormality of the labia minora (HP:0012880) | 1.76831487 |
| 169 | Hypoplastic female external genitalia (HP:0012815) | 1.76728785 |
| 170 | Severe muscular hypotonia (HP:0006829) | 1.76474168 |
| 171 | Heart block (HP:0012722) | 1.75325360 |
| 172 | Hypomagnesemia (HP:0002917) | 1.74955159 |
| 173 | Sclerocornea (HP:0000647) | 1.74887749 |
| 174 | Occipital encephalocele (HP:0002085) | 1.74340927 |
| 175 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.73577954 |
| 176 | Hypoplasia of the fovea (HP:0007750) | 1.73577954 |
| 177 | Albinism (HP:0001022) | 1.72773804 |
| 178 | Acanthocytosis (HP:0001927) | 1.72177429 |
| 179 | Torticollis (HP:0000473) | 1.72161292 |
| 180 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.70603253 |
| 181 | Insulin resistance (HP:0000855) | 1.70185785 |
| 182 | Congenital malformation of the right heart (HP:0011723) | 1.70114210 |
| 183 | Double outlet right ventricle (HP:0001719) | 1.70114210 |
| 184 | Toxemia of pregnancy (HP:0100603) | 1.69828130 |
| 185 | Bundle branch block (HP:0011710) | 1.69700103 |
| 186 | Acute hepatic failure (HP:0006554) | 1.68243507 |
| 187 | Abnormal atrioventricular conduction (HP:0005150) | 1.67147001 |
| 188 | Action tremor (HP:0002345) | 1.66604096 |
| 189 | Polycythemia (HP:0001901) | 1.66118440 |
| 190 | Focal seizures (HP:0007359) | 1.65700047 |
| 191 | Lymphangioma (HP:0100764) | 1.64936545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.87118478 |
| 2 | CASK | 3.51575990 |
| 3 | INSRR | 3.07344163 |
| 4 | EPHA4 | 3.03677491 |
| 5 | NUAK1 | 2.86051718 |
| 6 | GRK1 | 2.72307959 |
| 7 | TRIB3 | 2.71316765 |
| 8 | SIK1 | 2.66578659 |
| 9 | BRSK2 | 2.63760009 |
| 10 | RIPK1 | 2.61159854 |
| 11 | STK24 | 2.60797982 |
| 12 | BCKDK | 2.57460354 |
| 13 | DAPK2 | 2.48877182 |
| 14 | NTRK3 | 2.37196997 |
| 15 | ERN1 | 2.24353568 |
| 16 | MAP4K2 | 2.14031045 |
| 17 | ADRBK2 | 2.10975503 |
| 18 | EIF2AK3 | 1.99113286 |
| 19 | FRK | 1.94491923 |
| 20 | MUSK | 1.94128855 |
| 21 | MKNK2 | 1.88914432 |
| 22 | WNK3 | 1.78487536 |
| 23 | STK39 | 1.75356636 |
| 24 | STK38L | 1.68856082 |
| 25 | OXSR1 | 1.64355714 |
| 26 | MAP3K2 | 1.62094405 |
| 27 | MAP2K4 | 1.55992068 |
| 28 | FGFR4 | 1.51205875 |
| 29 | PINK1 | 1.48479128 |
| 30 | PRKD3 | 1.40687596 |
| 31 | TLK1 | 1.40631677 |
| 32 | ERBB3 | 1.39719493 |
| 33 | WNK4 | 1.38560573 |
| 34 | LATS1 | 1.32737438 |
| 35 | MAP3K7 | 1.32691210 |
| 36 | SGK3 | 1.32592958 |
| 37 | PKN2 | 1.30251498 |
| 38 | TAOK3 | 1.29645474 |
| 39 | MAPK13 | 1.28535271 |
| 40 | TAOK2 | 1.26361224 |
| 41 | TAOK1 | 1.26107589 |
| 42 | BMPR1B | 1.25447677 |
| 43 | TRIM28 | 1.24503983 |
| 44 | CAMK1D | 1.23568240 |
| 45 | FGFR2 | 1.20975563 |
| 46 | SGK2 | 1.20396948 |
| 47 | CAMK1G | 1.17377233 |
| 48 | TNIK | 1.17172648 |
| 49 | WEE1 | 1.16311399 |
| 50 | CAMKK1 | 1.13805398 |
| 51 | PHKG2 | 1.13669898 |
| 52 | PHKG1 | 1.13669898 |
| 53 | LMTK2 | 1.11951121 |
| 54 | DMPK | 1.11384229 |
| 55 | MAP3K4 | 1.10686055 |
| 56 | TTN | 1.10354834 |
| 57 | PRKAA2 | 1.10187299 |
| 58 | CSNK1G1 | 1.08919266 |
| 59 | PRKCI | 1.08705422 |
| 60 | PRKCE | 1.04712208 |
| 61 | PTK6 | 1.03933121 |
| 62 | STK38 | 1.03698346 |
| 63 | NTRK1 | 1.03074817 |
| 64 | ZAK | 1.03032686 |
| 65 | PLK2 | 0.98693419 |
| 66 | MAP3K3 | 0.98252046 |
| 67 | PAK3 | 0.95053847 |
| 68 | EIF2AK1 | 0.94879196 |
| 69 | MST1R | 0.94847054 |
| 70 | MAP3K1 | 0.91495013 |
| 71 | CSNK1G3 | 0.90995046 |
| 72 | FLT3 | 0.89790282 |
| 73 | PRKCH | 0.89373556 |
| 74 | CSNK1G2 | 0.87232672 |
| 75 | FGFR3 | 0.86972936 |
| 76 | MYLK | 0.86468485 |
| 77 | MAPK15 | 0.86128452 |
| 78 | SGK223 | 0.85858458 |
| 79 | SGK494 | 0.85858458 |
| 80 | KSR2 | 0.84233154 |
| 81 | NLK | 0.83400134 |
| 82 | MAPKAPK3 | 0.82642064 |
| 83 | TNK2 | 0.81479757 |
| 84 | ACVR1B | 0.80712967 |
| 85 | MAP3K9 | 0.79964899 |
| 86 | MARK2 | 0.79137539 |
| 87 | PTK2B | 0.77548008 |
| 88 | CAMK1 | 0.76616171 |
| 89 | CAMKK2 | 0.76474323 |
| 90 | TIE1 | 0.75991706 |
| 91 | RET | 0.75831379 |
| 92 | OBSCN | 0.75147418 |
| 93 | CSNK1A1L | 0.75063469 |
| 94 | NTRK2 | 0.72527019 |
| 95 | SIK2 | 0.72385024 |
| 96 | PRKAA1 | 0.72300694 |
| 97 | IKBKB | 0.71236276 |
| 98 | PIK3CA | 0.70656343 |
| 99 | PDPK1 | 0.69701789 |
| 100 | MAP2K3 | 0.69118964 |
| 101 | TRPM7 | 0.68903674 |
| 102 | TEC | 0.68383145 |
| 103 | MAPK12 | 0.68212582 |
| 104 | PRKCQ | 0.67866755 |
| 105 | STK3 | 0.67718355 |
| 106 | SGK1 | 0.66842986 |
| 107 | JAK2 | 0.66745052 |
| 108 | PTK2 | 0.66661274 |
| 109 | JAK1 | 0.66339946 |
| 110 | STK11 | 0.66302815 |
| 111 | CAMK4 | 0.65963866 |
| 112 | RIPK4 | 0.65088574 |
| 113 | DAPK1 | 0.64121848 |
| 114 | PDGFRA | 0.62171638 |
| 115 | EPHA3 | 0.61870035 |
| 116 | AKT3 | 0.60797530 |
| 117 | PRKCZ | 0.60155327 |
| 118 | PRKACG | 0.59610609 |
| 119 | CAMK2G | 0.59328802 |
| 120 | MINK1 | 0.59279854 |
| 121 | MAPK7 | 0.59141238 |
| 122 | ADRBK1 | 0.58700095 |
| 123 | CDK5 | 0.58390903 |
| 124 | MAP2K6 | 0.58244887 |
| 125 | EPHB1 | 0.58134098 |
| 126 | STK10 | 0.57962421 |
| 127 | HIPK2 | 0.57468474 |
| 128 | PDK1 | 0.55026600 |
| 129 | FES | 0.54827321 |
| 130 | FER | 0.54600367 |
| 131 | MAP2K1 | 0.54464231 |
| 132 | CHUK | 0.53726423 |
| 133 | CDC42BPA | 0.53594422 |
| 134 | PRKD1 | 0.51805386 |
| 135 | PRKCG | 0.51282373 |
| 136 | PRKD2 | 0.50658325 |
| 137 | BCR | 0.49692618 |
| 138 | CAMK2A | 0.48868913 |
| 139 | BRSK1 | 0.48170724 |
| 140 | PAK6 | 0.48120665 |
| 141 | MAPK11 | 0.48035324 |
| 142 | RPS6KA3 | 0.47899811 |
| 143 | PIK3CG | 0.47887227 |
| 144 | MKNK1 | 0.46491781 |
| 145 | ERBB2 | 0.45913775 |
| 146 | CAMK2D | 0.45786943 |
| 147 | SIK3 | 0.43053119 |
| 148 | PRKACA | 0.39956581 |
| 149 | PNCK | 0.38684333 |
| 150 | CSNK1A1 | 0.36440571 |
| 151 | GRK5 | 0.35644118 |
| 152 | PLK3 | 0.35493104 |
| 153 | EIF2AK2 | 0.33932975 |
| 154 | PRKG1 | 0.33789971 |
| 155 | VRK1 | 0.33569077 |
| 156 | ROCK1 | 0.33553059 |
| 157 | ABL1 | 0.32739831 |
| 158 | EPHA2 | 0.32201306 |
| 159 | IRAK1 | 0.31963109 |
| 160 | PRKCA | 0.28554646 |
| 161 | GRK7 | 0.27521091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.63896964 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.29265356 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.18828019 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.75675104 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.71709045 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.61543777 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.47173657 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.41146948 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39663367 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.10202721 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.02972911 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99836576 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.95628809 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89951905 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87430852 |
| 16 | Bile secretion_Homo sapiens_hsa04976 | 1.83149985 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.80659104 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78616667 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77808008 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.77331713 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.71768705 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.71219845 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.70804191 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.68506455 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.67441976 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.64340053 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59274809 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.52850986 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48018216 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46068513 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42448674 |
| 32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.41887322 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41171992 |
| 34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.38258017 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.37937605 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36691104 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31665179 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.31073001 |
| 39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28358519 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26767819 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25551814 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25277757 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.23718290 |
| 44 | RNA degradation_Homo sapiens_hsa03018 | 1.22787731 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.20798023 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20117239 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17471564 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16074315 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.15530289 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15059960 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13810169 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12646932 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11807285 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 1.10423231 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.09756482 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 1.09349700 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07721799 |
| 58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.06954091 |
| 59 | Homologous recombination_Homo sapiens_hsa03440 | 1.05687380 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03593682 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02426153 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02141735 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 1.01452133 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95888044 |
| 65 | * Circadian entrainment_Homo sapiens_hsa04713 | 0.94210246 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93039461 |
| 67 | RNA polymerase_Homo sapiens_hsa03020 | 0.92953398 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92072277 |
| 69 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91861069 |
| 70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.91228217 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.88720520 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87472782 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.84544914 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83158675 |
| 75 | Nicotine addiction_Homo sapiens_hsa05033 | 0.82105811 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.81453186 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80980546 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80701272 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78924554 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78652093 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78347391 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77093292 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.76126126 |
| 84 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75665655 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75220912 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.75155922 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74367132 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73969955 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72970859 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.72502137 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72288829 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.71736698 |
| 93 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69730550 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.69017299 |
| 95 | Proteasome_Homo sapiens_hsa03050 | 0.68366980 |
| 96 | Parkinsons disease_Homo sapiens_hsa05012 | 0.68161434 |
| 97 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67762552 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67630890 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67060986 |
| 100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62348416 |
| 101 | * Circadian rhythm_Homo sapiens_hsa04710 | 0.61841134 |
| 102 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61825242 |
| 103 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61216193 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60985610 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59602322 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59371950 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57898724 |
| 108 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57351683 |
| 109 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55592897 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55557609 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55555123 |
| 112 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.54808204 |
| 113 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54328968 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54055110 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54003401 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53949018 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53533793 |
| 118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51544312 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51359879 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51199719 |
| 121 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51100669 |
| 122 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50974116 |
| 123 | Long-term depression_Homo sapiens_hsa04730 | 0.50593020 |
| 124 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49709115 |
| 125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49010070 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48494361 |
| 127 | Purine metabolism_Homo sapiens_hsa00230 | 0.48044309 |
| 128 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47873400 |
| 129 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47121184 |
| 130 | Huntingtons disease_Homo sapiens_hsa05016 | 0.47038210 |
| 131 | Taste transduction_Homo sapiens_hsa04742 | 0.46505839 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44192556 |
| 133 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43670581 |
| 134 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.43609202 |
| 135 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42912697 |
| 136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42782657 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41962689 |
| 138 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.41386861 |
| 139 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40409237 |
| 140 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40256506 |
| 141 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37708053 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36606735 |
| 143 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34989238 |
| 144 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34134132 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34024178 |

